Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth
Publication
, Journal Article
McDonnell, E; Ilkayeva, OR; Stevens, RD; Muehlbauer, MJ; Bain, JR; Becker, TC; Hirschey, MD
Published in: Cancer & metabolism
January 2014
Duke Scholars
Published In
Cancer & metabolism
DOI
EISSN
2049-3002
ISSN
2049-3002
Publication Date
January 2014
Volume
2
Issue
Suppl 1
Start / End Page
O18 / O18
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3205 Medical biochemistry and metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
McDonnell, E., Ilkayeva, O. R., Stevens, R. D., Muehlbauer, M. J., Bain, J. R., Becker, T. C., & Hirschey, M. D. (2014). Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth. Cancer & Metabolism, 2(Suppl 1), O18–O18. https://doi.org/10.1186/2049-3002-2-s1-o18
McDonnell, Eoin, Olga R. Ilkayeva, Robert D. Stevens, Michael J. Muehlbauer, James R. Bain, Tomas C. Becker, and Matthew D. Hirschey. “Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth.” Cancer & Metabolism 2, no. Suppl 1 (January 2014): O18–O18. https://doi.org/10.1186/2049-3002-2-s1-o18.
McDonnell E, Ilkayeva OR, Stevens RD, Muehlbauer MJ, Bain JR, Becker TC, et al. Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth. Cancer & metabolism. 2014 Jan;2(Suppl 1):O18–O18.
McDonnell, Eoin, et al. “Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth.” Cancer & Metabolism, vol. 2, no. Suppl 1, Jan. 2014, pp. O18–O18. Epmc, doi:10.1186/2049-3002-2-s1-o18.
McDonnell E, Ilkayeva OR, Stevens RD, Muehlbauer MJ, Bain JR, Becker TC, Hirschey MD. Loss of SIRT3 leads to a compensatory shift in cellular metabolism promoting cancer cell growth. Cancer & metabolism. 2014 Jan;2(Suppl 1):O18–O18.
Published In
Cancer & metabolism
DOI
EISSN
2049-3002
ISSN
2049-3002
Publication Date
January 2014
Volume
2
Issue
Suppl 1
Start / End Page
O18 / O18
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3205 Medical biochemistry and metabolomics